Taken together, these results suggested that inhibiting lncRNA Dlx6-os1 expression in kidney podocytes could represent an effective approach to alleviate the podocyte injury, inflammation, and albuminuria associated with DN. This evidence concerns the gene DLX6 and liver dysplastic nodule.